Vaccines
18 April 2025
Magnet-Like Nanoparticle Vaccine Achieves 100% Protection Against H5N1 in Preclinical Trials16 April 2025
Sabin Begins Marburg Vaccine Trial in U.S.7 April 2025
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention2 April 2025
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial27 March 2025
Preclinical Intranasal COVID-19 Vaccine Candidate Data Demonstrate Durable Immune Response and Broad Protection24 March 2025
Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM1424 March 2025
Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-10193 March 2025
DIOSynVax Presents Promising Bird Flu Vaccine Data in Late Breaker Session at the 2025 AAAAI Annual Meeting26 February 2025
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate17 February 2025
LimmaTech Vaccinates First Participants in Phase 1 Study of Staphylococcus aureus Vaccine Candidate LBT-SA717 February 2025
Penmenvy, GSK’s 5-in-1 meningococcal vaccine, approved by US FDA to help protect against MenABCWYNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports